MedTrace Logo

Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients

NCT03444259 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1001

Last updated 2024-05-08

No results posted yet for this study

Summary

The objective of CAREBANK study is to establish definitive relationships with human cardiac samples and clinical phenotypes in patients undergoing cardiac procedures. Specifically, the investigators aim at comparing atrial phenotypes from atrial fibrillation patients and controls. The work consists of three broad categories: A) role of atrial cardiomyopathy in atrial fibrillation; B) genetic defects predisposing to atrial fibrillation; and C) the role of inflammation in atrial fibrillation.

Conditions

Interventions

PROCEDURE

Cardiac surgery

Open heart surgery

Sponsors & Collaborators

  • Brigham and Women's Hospital

    collaborator OTHER

  • University of Turku

    lead OTHER

Principal Investigators

  • Tuomas O Kiviniemi, MD, PhD · Turku University Hospital

  • Jarmo Gunn, MD, PhD · Turku University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-01
Primary Completion
2026-12-31
Completion
2029-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03444259 on ClinicalTrials.gov